Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Vos

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Investigative Radiology|April 14, 2015
Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate CancerEline K Vos, Thiele Kobus, Geert J S Litjens, et al.
Magnetic Resonance in Medicine|June 27, 2013
Feasibility of T2 -weighted turbo spin echo imaging of the human prostate at 7 teslaMarnix C Maas, Eline K Vos, Miriam W Lagemaat, et al.
European Radiology|May 29, 2014
Image quality and cancer visibility of T2-weighted magnetic resonance imaging of the prostate at 7 TeslaE K Vos, M W Lagemaat, J O Barentsz, et al.
Annals of the Rheumatic Diseases|June 30, 2000
Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditionsK Vos, P Steenbakkers, A M Miltenburg, et al.
Magnetic Resonance in Medicine|March 29, 2014
(31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterizationMiriam W Lagemaat, Marnix C Maas, Eline K Vos, et al.
Annals of the Rheumatic Diseases|July 24, 2008
A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissueA W R van Kuijk, D M Gerlag, K Vos, et al.
Annals of the Rheumatic Diseases|December 7, 2007
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synoviumC A Wijbrandts, M G W Dijkgraaf, M C Kraan, et al.
Annals of the Rheumatic Diseases|August 4, 2010
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activityT Groot Kormelink, J Tekstra, R M Thurlings, et al.
Annals of the Rheumatic Diseases|July 17, 2009
A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritisB J F van den Bemt, K Vos, A A den Broeder, et al.
Arthritis and Rheumatism|July 9, 2003
Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritisL R Lard, F A van Gaalen, J J M Schonkeren, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Investigative Radiology|April 14, 2015
Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate CancerEline K Vos, Thiele Kobus, Geert J S Litjens, et al.
Magnetic Resonance in Medicine|June 27, 2013
Feasibility of T2 -weighted turbo spin echo imaging of the human prostate at 7 teslaMarnix C Maas, Eline K Vos, Miriam W Lagemaat, et al.
European Radiology|May 29, 2014
Image quality and cancer visibility of T2-weighted magnetic resonance imaging of the prostate at 7 TeslaE K Vos, M W Lagemaat, J O Barentsz, et al.
Annals of the Rheumatic Diseases|June 30, 2000
Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditionsK Vos, P Steenbakkers, A M Miltenburg, et al.
Magnetic Resonance in Medicine|March 29, 2014
(31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterizationMiriam W Lagemaat, Marnix C Maas, Eline K Vos, et al.
Annals of the Rheumatic Diseases|July 24, 2008
A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissueA W R van Kuijk, D M Gerlag, K Vos, et al.
Annals of the Rheumatic Diseases|December 7, 2007
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synoviumC A Wijbrandts, M G W Dijkgraaf, M C Kraan, et al.
Annals of the Rheumatic Diseases|August 4, 2010
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activityT Groot Kormelink, J Tekstra, R M Thurlings, et al.
Annals of the Rheumatic Diseases|July 17, 2009
A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritisB J F van den Bemt, K Vos, A A den Broeder, et al.
Arthritis and Rheumatism|July 9, 2003
Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritisL R Lard, F A van Gaalen, J J M Schonkeren, et al.
Pageof 13